M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_36566

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_36566 40 0.83 Mlig455_053263

Neo: -

Age: -

Region-enriched R2: 4.823/0.01830

 Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871}

Cumulative graph for MligTC455_36566

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -2.798 1.236 1.00000 1.00000
RegionR2 4.823 1.236 0.00078 0.01830
RegionR3 0.392 1.236 0.59476 1.00000
RegionR4 2.549 1.236 0.05896 0.21564
RegionR5 0.263 1.236 0.67302 1.00000
RegionR6 -1.429 1.236 1.00000 1.00000
RegionR7 -1.858 1.236 1.00000 1.00000
RegionR8 -1.942 1.236 1.00000 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -0.477 1.236 1.00000 1.00000
RegenerationR2 -1.652 1.236 0.08932 0.47802
RegenerationR3 0.741 1.236 0.60771 0.91167
RegenerationR4 -0.813 1.236 0.50475 0.87144
RegenerationR5 1.702 1.236 0.20089 0.63368
RegenerationR6 1.006 1.236 0.44598 0.76779
RegenerationBL -0.762 1.236 1.00000 1.00000
RegenerationTP 4.29 1.236 0.11040 0.51088


Genes with expression patterns similar to MligTC455_36566

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_36566 40 0.83 Mlig455_053263

Neo: -

Age: -

Region-enriched R2: 4.823/0.01830

 4 - 1.000 1.000 1.000 1.000 - Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871}
2. MligTC455_10227 76 1.59 Mlig455_023507, Mlig455_023516, Mlig455_023551

Neo: -

Age: -

 3.729 - 0.982 0.968 0.806 0.973 -

Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050}

Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050}

Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1}
3. MligTC455_10229 24 0.49 Mlig455_023615

Neo: -

Age: -

 3.728 - 0.982 0.968 0.806 0.972 - Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050}
4. MligTC455_17394 41 0.85 Mlig455_013077

Neo: -

Age: -

 3.702 - 0.993 0.979 0.753 0.977 - Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868}
5. MligTC455_52507 60 1.26 Mlig455_016440

Neo: -

Age: -

Region-enriched R2: 5.871/0.01204

 3.651 - 0.942 0.934 0.802 0.973 - Mlig455_016440 {REF} {Length: 1576} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_98267}
6. MligTC455_08408 41 0.86 Mlig455_043171

Neo: -

Age: Up-Down-Down

 3.646 - 0.982 0.875 0.809 0.980 - Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360}
7. MligTC455_13902 400 8.32 Mlig455_011022, Mlig455_011835, Mlig455_013117

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.562

Region-specific R2: 6.064

Region-enriched R2: 5.080/0.00072

 3.624 - 0.995 0.820 0.843 0.966 -

Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856}

Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856}

Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2}
8. MligTC455_43137 118 2.46 Mlig455_043159

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-1.878

Region-enriched R2: 5.988/0.00166
Region-enriched R4: 3.958/0.04103

 3.604 - 0.992 0.887 0.799 0.926 - Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317}
9. MligTC455_15353 85 1.78 Mlig455_015663, Mlig455_062473

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-1.265

Region-enriched R2: 9.386/0.02025

 ARRB1 3.602 - 0.959 0.866 0.809 0.968 -

Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1}

Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1}
10. MligTC455_30634 114 2.38 Mlig455_025888

Neo: -

Age: Up-Down-Up

Region-enriched R2: 6.750/0.00140

 3.599 - 0.996 0.882 0.789 0.932 - Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1}
11. MligTC455_44725 67 1.4 Mlig455_024194

Neo: -

Age: -

 3.589 - 0.995 0.842 0.780 0.972 - Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586}
12. MligTC455_10226 119 2.48 Mlig455_023508, Mlig455_023518, Mlig455_023617

Neo: -

Age: -

 3.562 - 0.986 0.796 0.806 0.974 -

Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050}

Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050}

Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050}
13. MligTC455_47110 34 0.7 Mlig455_025028

Neo: -

Age: -

 3.532 - 0.972 0.802 0.785 0.973 - Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240}
14. MligTC455_45811 216 4.5 Mlig455_015628

Neo: -

Age: Down-Up-Down

Region-enriched R2: 5.807/0.00004

 3.494 - 0.981 0.789 0.828 0.896 - Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238}
15. MligTC455_41443 382 7.96 Mlig455_034791, Mlig455_034803

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-1.360

Region-enriched R2: 5.869/0.00205

 3.492 - 0.994 0.772 0.806 0.920 -

Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421}

Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421}
16. MligTC455_10228 50 1.05 Mlig455_023553

Neo: -

Age: -

 3.48 - 0.986 0.717 0.803 0.974 - Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050}
17. MligTC455_35103 102 2.12 Mlig455_023928

Neo: -

Age: logFC(26M/2M)=-1.570

Region-enriched R2: 8.161/0.00000

 OPN4 3.477 - 0.996 0.837 0.805 0.839 - Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962}
18. MligTC455_18140 171 3.56 Mlig455_033232

Neo: -

Age: Up-Down-Down

Region-specific R2: 6.925

Region-enriched R2: 6.274/0.02921

 TRPC5 3.448 - 0.990 0.822 0.816 0.820 - Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637}
19. MligTC455_11776 33 0.68 Mlig455_048959

Neo: -

Age: -

 GABBR2 3.41 - 0.809 0.824 0.809 0.968 - Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524}
20. MligTC455_18139 70 1.45 Mlig455_010809

Neo: -

Age: logFC(26M/2M)=-0.809

Region-enriched R2: 6.868/0.00081

 TRPC5 3.405 - 0.978 0.716 0.777 0.934 - Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637}
21. MligTC455_11558 137 2.85 Mlig455_058259

Neo: -

Age: logFC(26M/2M)=-0.792

 3.362 - 0.782 0.807 0.807 0.966 - Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876}
22. MligTC455_25703 225 4.7 Mlig455_017402, Mlig455_030916

Neo: -

Age: -

 3.344 - 0.956 0.706 0.807 0.875 -

Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527}

Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527}
23. MligTC455_42520 221 4.6 Mlig455_051277

Neo: -

Age: Down-Up-Up

Region-specific R2: 7.331

Region-enriched R2: 7.171/0.00000

Regeneration-downregulated R2: -3.384

Regeneration-depleted R2: -3.384

 3.329 - 0.969 0.754 0.789 0.817 - Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649}
24. MligTC455_47259 985 20.52 Mlig455_024978

Neo: -

Age: -

Region-enriched R2: 2.522/0.00122

 3.307 - 0.967 0.757 0.763 0.820 - Mlig455_024978 {REF} {Length: 514} {RNA1310_63739.2} {RNA815_33907}
25. MligTC455_41854 80 1.67 Mlig455_034307, Mlig455_067305, Mlig455_067321

Neo: -

Age: -

 3.303 - 0.831 0.709 0.790 0.973 -

Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1}

Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1}

Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1}
26. MligTC455_44956 144 2.99 Mlig455_061510

Neo: -

Age: -

 3.263 - 0.772 0.712 0.811 0.968 - Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767}
27. MligTC455_15182 24 0.49 Mlig455_008075

Neo: -

Age: -

 3.249 - 0.701 0.820 0.745 0.983 - Mlig455_008075 {REF} {Length: 1623} {RNA1310_145272}
28. MligTC455_51807 28 0.59 Mlig455_046394

Neo: -

Age: -

 GPSM2 2.856 - 0.972 0.919 - 0.965 - Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322}
29. MligTC455_17363 62 1.28 Mlig455_003936

Neo: -

Age: -

 2.801 - 0.999 - 0.814 0.988 - Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646}
30. MligTC455_49285 164 3.41 Mlig455_004486, Mlig455_037380

Neo: -

Age: -

Region-specific R2: 6.095

Region-enriched R2: 5.942/0.00244

 LEF1 2.773 - 0.993 - 0.824 0.956 -

Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141}

Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141}
31. MligTC455_12269 42 0.88 Mlig455_062448

Neo: -

Age: -

Region-enriched R2: 6.351/0.02912

 2.77 - 0.998 - 0.836 0.936 - Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238}
32. MligTC455_35000 20 0.42 Mlig455_050562

Neo: -

Age: -

 KCNC1 2.749 - 0.963 0.824 - 0.962 - Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040}
33. MligTC455_44724 186 3.88 Mlig455_024176

Neo: -

Age: -

Region-enriched R7: 3.890/0.00870

 2.74 - 0.969 - 0.801 0.970 - Mlig455_024176 {REF} {Length: 967} {RNA1310_84543} {RNA815_47586}
34. MligTC455_53658 41 0.86 Mlig455_070698

Neo: -

Age: Up-Down-Down

Region-enriched R2: 9.084/0.01491

 2.74 - 0.993 0.801 - 0.946 - Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004}
35. MligTC455_37701 47 0.98 Mlig455_029831

Neo: -

Age: -

Region-enriched R2: 8.298/0.02665

 2.739 - 0.998 - 0.809 0.932 - Mlig455_029831 {REF} {Length: 724} {RNA1310_73844}
36. MligTC455_49922 36 0.76 Mlig455_049338

Neo: -

Age: Down-Down-Up

Region-enriched R2: 7.622/0.00496

 2.737 - 0.978 0.843 - 0.916 - Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585}
37. MligTC455_42240 80 1.66 Mlig455_038267

Neo: -

Age: Down-Up-Down

 2.73 - 0.977 - 0.915 0.838 - Mlig455_038267 {REF} {Length: 989} {RNA1310_36501} {RNA815_32545}
38. MligTC455_27678 355 7.4 Mlig455_070610

Neo: -

Age: -

Region-specific R2: 4.724

Region-enriched R2: 3.766/0.00062

 2.73 - 0.949 0.827 - 0.954 - Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024}
39. MligTC455_52527 28 0.58 Mlig455_025836

Neo: -

Age: -

 FLVCR2 2.712 - 0.977 0.792 - 0.943 - Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234}
40. MligTC455_40040 365 7.61 Mlig455_008332

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.784

Region-specific R2: 6.834

Region-enriched R2: 5.705/0.00005

 2.707 - 0.987 - 0.833 0.887 - Mlig455_008332 {REF} {Length: 707} {RNA1509_39735} {RNA1310_73916, RNA1509_39735} {RNA1509_39735, RNA815_42730.2}
41. MligTC455_53657 221 4.6 Mlig455_039396

Neo: -

Age: -

Region-enriched R2: 6.078/0.00340

 2.705 - 0.988 - 0.790 0.927 - Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004}
42. MligTC455_31172 195 4.06 Mlig455_028354

Neo: -

Age: -

Region-enriched R5: 4.005/0.04475

 2.689 - 0.990 - 0.789 0.910 - Mlig455_028354 {REF} {Length: 2036} {RNA1310_45498} {RNA815_15412}
43. MligTC455_17479 32 0.66 Mlig455_032081, Mlig455_070278

Neo: -

Age: logFC(26M/2M)=-0.516

 CHRNA3 2.683 - 0.974 0.824 - 0.885 -

Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960}

Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960}
44. MligTC455_13903 648 13.5 Mlig455_013116

Neo: -

Age: logFC(26M/2M)=-1.026

Region-specific R2: 6.980

Region-enriched R2: 7.338/0.00000

 2.675 - 0.999 - 0.719 0.957 - Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856}
45. MligTC455_48604 173 3.6 Mlig455_031074

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-1.490

 2.67 - 0.904 - 0.807 0.959 - Mlig455_031074 {REF} {Length: 652} {RNA1310_66509}
46. MligTC455_09557 33 0.68 Mlig455_059478

Neo: -

Age: Up-Down-Down

 B3GNT4 2.66 - 0.965 0.728 - 0.967 - Mlig455_059478 {REF} {Length: 2800} {Pfam: Galactosyltransferase [PF01762.23, score=72.9]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=75.9, Expect=2e-14]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=73.6, Expect=1e-13]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=110, Expect=5e-27]} {RNA1310_43488}
47. MligTC455_11109 30 0.62 Mlig455_043718, Mlig455_043804

Neo: -

Age: Up-Down-Down

 2.66 - 0.959 - 0.795 0.906 -

Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415}

Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415}
48. MligTC455_09874 31 0.65 Mlig455_045071

Neo: -

Age: -

 DOC2A 2.658 - 0.982 - 0.706 0.970 - Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844}
49. MligTC455_30160 55 1.15 Mlig455_035128

Neo: -

Age: -

Region-enriched R2: 5.270/0.01686

 TCF7L1 2.654 - 0.860 - 0.827 0.967 - Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690}
50. MligTC455_47997 36 0.75 Mlig455_053262, Mlig455_065031

Neo: -

Age: -

 2.652 - 0.982 0.842 0.828 - -

Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2}

Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2}
51. MligTC455_23220 56 1.18 Mlig455_060190

Neo: -

Age: -

 ACKR3 2.641 - 0.952 - 0.772 0.917 - Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432}
52. MligTC455_44966 574 11.95 Mlig455_036578, Mlig455_057773

Neo: -

Age: Down-Down-Up, logFC(26M/2M)=-0.756

Region-specific R2: 7.016

Region-enriched R2: 7.690/0.00000

 2.63 - 0.856 - 0.816 0.958 -

Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388}

Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388}
53. MligTC455_30159 107 2.22 Mlig455_008465, Mlig455_009916

Neo: -

Age: Up-Down-Down

Region-enriched R2: 4.961/0.00498

 TCF7L1 2.608 - 0.859 - 0.799 0.950 -

Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690}

Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690}
54. MligTC455_16248 132 2.74 Mlig455_038325, Mlig455_050222, Mlig455_050231

Neo: -

Age: -

 CHRNA3 2.604 - 0.982 - 0.901 0.721 -

Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042}

Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042}

Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042}
55. MligTC455_20730 43 0.9 Mlig455_050491, Mlig455_050492

Neo: -

Age: -

 GABBR2 2.603 - - 0.832 0.802 0.969 -

Mlig455_050491 {REF} {Length: 2570} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=128.2]; Receptor family ligand binding region [PF01094.30, score=119.0]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=236, Expect=1e-65]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=234, Expect=4e-65]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=250, Expect=3e-70]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=206, Expect=4e-56]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=108, Expect=2e-26]} {RNA1310_11554} {RNA815_30781}

Mlig455_050492 {REF} {Length: 3107} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=130.0]; Receptor family ligand binding region [PF01094.30, score=118.1]; Phage integrase family [PF00589.24, score=28.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=233, Expect=2e-63]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=233, Expect=1e-63]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=258, Expect=2e-71]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=210, Expect=2e-56]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=118, Expect=1e-29]} {RNA1310_11554} {RNA815_30781}
56. MligTC455_49919 745 15.52 Mlig455_017182, Mlig455_048150

Neo: -

Age: -

Region-specific R2: 7.180

Region-enriched R2: 7.978/0.00000

Regeneration-downregulated R2: -4.649

Regeneration-depleted R2: -4.649

 2.594 - 0.816 - 0.818 0.960 -

Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347}

Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347}
57. MligTC455_08098 15 0.31 Mlig455_029099

Neo: -

Age: -

Region-enriched R2: 8.013/0.00338

 2.589 - 0.982 0.768 - 0.839 - Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110}
58. MligTC455_53720 144 2.99 Mlig455_028516

Neo: -

Age: -

Region-enriched R2: 4.205/0.01762

 CTBP2 2.582 - 0.882 - 0.746 0.954 - Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484}
59. MligTC455_36567 18 0.37 Mlig455_065030

Neo: -

Age: -

 2.576 - 0.983 0.803 0.790 - - Mlig455_065030 {REF} {Length: 672}
60. MligTC455_17966 1490 31.04 Mlig455_026737

Neo: -

Age: logFC(26M/2M)=-0.346

Region-specific R2: 3.759

Region-enriched R2: 2.729/0.00000
Region-enriched R6: 1.885/0.00048

Regeneration-downregulated R6: -2.271

Regeneration-depleted R6: -2.271

 2.565 - 0.954 - 0.761 0.850 - Mlig455_026737 {REF} {Length: 1222} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.3]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=26.5]; Protein of unknown function (DUF559) [PF04480.14, score=20.7]; REase_MTES_1575 [PF18741.3, score=20.0]} {RNA1509_18273} {RNA1310_34603.1} {RNA815_20381}
61. MligTC455_47197 155 3.24 Mlig455_049096, Mlig455_049118

Neo: -

Age: -

 2.565 - 0.997 0.715 - 0.853 -

Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725}

Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725}
62. MligTC455_53128 27 0.57 Mlig455_070169

Neo: -

Age: -

 ATL1 2.565 - 0.772 0.821 - 0.972 - Mlig455_070169 {REF} {Length: 1728} {Pfam: Guanylate-binding protein, N-terminal domain [PF02263.21, score=60.7]} {Human: ENSG00000198513, ATL1, atlastin GTPase 1, [Score=127, Expect=5e-31]; ENSG00000119787, ATL2, atlastin GTPase 2, [Score=121, Expect=1e-29]} {Mouse: ENSMUSG00000021066, Atl1, atlastin GTPase 1, [Score=125, Expect=1e-30]; ENSMUSG00000059811, Atl2, atlastin GTPase 2, [Score=122, Expect=5e-30]} {Dmel: FBgn0039213, atl, atlastin, [Score=117, Expect=6e-28]} {Celegans: WBGene00012763, atln-2, ATLastiN (Endoplasmic reticulum GTPase) related, [Score=115, Expect=1e-28]} {Smed: dd_Smed_v6_4450_0_1, dd_Smed_v6_4450_0_1, [Score=97.8, Expect=1e-21]} {RNA1509_32178} {RNA1310_34862} {RNA815_28130}
63. MligTC455_49923 118 2.47 Mlig455_049416

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-1.442

Region-enriched R2: 7.940/0.00000

Regeneration-upregulated R4: 4.643

Regeneration-enriched R4: 4.643

 2.555 - 0.967 0.803 0.785 - - Mlig455_049416 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585}
64. MligTC455_43926 62 1.29 Mlig455_006882

Neo: -

Age: -

 2.545 - - 0.778 0.796 0.971 - Mlig455_006882 {REF} {Length: 585} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_18484} {RNA1310_77496} {RNA815_40214.1}
65. MligTC455_17967 3579 74.57 Mlig455_051723, Mlig455_051747

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.373

Region-enriched R2: 2.354/0.00024
Region-enriched R7: 1.586/0.02362
Region-enriched R6: 1.575/0.01589

 2.543 - 0.950 - 0.768 0.825 -

Mlig455_051723 {REF} {Length: 1123} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=33.4]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=21.7]; Protein of unknown function (DUF559) [PF04480.14, score=20.6]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381}

Mlig455_051747 {REF} {Length: 1166} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.0]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=25.9]; Protein of unknown function (DUF559) [PF04480.14, score=22.5]; REase_MTES_1575 [PF18741.3, score=20.8]; CW_7 repeat [PF08230.13, score=19.3]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381}
66. MligTC455_12607 22 0.46 Mlig455_022861

Neo: -

Age: -

 2.542 - 0.953 0.824 0.765 - - Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283}
67. MligTC455_46430 62 1.29 Mlig455_057117, Mlig455_069301

Neo: -

Age: -

 GUCY2F 2.541 - 0.769 - 0.821 0.951 -

Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108}

Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181}
68. MligTC455_44954 1303 27.14 Mlig455_029595, Mlig455_070648

Neo: Int S/G2/M

Age: Down-Up-Up, logFC(26M/2M)=1.023

Region-specific R2: 8.846

Region-enriched R2: 10.764/0.00000

 2.522 - - 0.740 0.808 0.974 -

Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767}

Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767}
69. MligTC455_33850 80 1.67 Mlig455_015720

Neo: -

Age: -

Region-enriched R2: 4.134/0.00338

 2.503 - 0.969 - 0.760 0.774 - Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453}
70. MligTC455_46452 134 2.79 Mlig455_048151

Neo: -

Age: -

Region-specific R2: 6.389

Region-enriched R2: 7.075/0.00014

Regeneration-downregulated R2: -3.162

Regeneration-depleted R2: -3.162

 2.497 - 0.746 - 0.784 0.967 - Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352}
71. MligTC455_53839 106 2.21 Mlig455_008195, Mlig455_069578

Neo: -

Age: -

 2.493 - 0.723 - 0.800 0.970 -

Mlig455_008195 {REF} {Length: 2376} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=8e-08]} {RNA1310_37888} {RNA815_29107}

Mlig455_069578 {REF} {Length: 2376} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=8e-08]} {RNA1310_37888} {RNA815_29107}
72. MligTC455_48523 615 12.81 Mlig455_027573

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.661

Region-enriched R2: 5.785/0.00008
Region-enriched R3: 3.161/0.04686

 2.488 - 0.967 - 0.726 0.795 - Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574}
73. MligTC455_50694 602 12.54 Mlig455_058794, Mlig455_070066

Neo: -

Age: Down-Down-Up

Region-specific R2: 5.478

Region-enriched R2: 3.805/0.01454

 2.483 - 0.701 - 0.823 0.959 -

Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041}

Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041}
74. MligTC455_27860 132 2.75 Mlig455_028348

Neo: -

Age: Down-Up-Up

Region-enriched R5: 3.575/0.00470

 2.48 - 0.970 - 0.772 0.738 - Mlig455_028348 {REF} {Length: 2024} {RNA1310_45498} {RNA815_15412}
75. MligTC455_21583 64 1.33 Mlig455_001407, Mlig455_064265

Neo: -

Age: -

 PDE8A 2.474 - 0.790 - 0.714 0.970 -

Mlig455_001407 {REF} {Length: 4083} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=278.7]; PAS domain [PF13426.9, score=22.9]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=589, Expect=0.0]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=568, Expect=0.0]; ENSG00000284762, AC022414.1, phosphodiesterase 8B, [Score=565, Expect=0.0]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=579, Expect=0.0]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=569, Expect=0.0]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=357, Expect=4e-110]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=312, Expect=6e-94]} {Smed: dd_Smed_v6_10593_0_1, dd_Smed_v6_10593_0_1, [Score=410, Expect=2e-130]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009}

Mlig455_064265 {REF} {Length: 3769} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=279.8]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=519, Expect=2e-172]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=495, Expect=4e-162]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=499, Expect=1e-164]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=496, Expect=8e-164]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=361, Expect=5e-112]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_10593_0_2, dd_Smed_v6_10593_0_2, [Score=404, Expect=1e-128]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009}
76. MligTC455_50171 151 3.14 Mlig455_065462

Neo: -

Age: logFC(26M/2M)=0.548

Region-specific R2: 5.212

Region-enriched R2: 5.063/0.00089

Regeneration-downregulated R2: -2.783

Regeneration-depleted R2: -2.783

 SCNN1A 2.465 - 0.956 0.782 0.727 - - Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1}
77. MligTC455_12545 37 0.76 Mlig455_069121

Neo: -

Age: -

 2.459 - - 0.706 0.769 0.984 - Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125}
78. MligTC455_46543 178 3.7 Mlig455_000344, Mlig455_067946

Neo: -

Age: -

Region-specific R2: 6.098

Region-enriched R2: 6.851/0.00000

 2.445 - - 0.763 0.720 0.962 -

Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120}

Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435}
79. MligTC455_23543 79 1.65 Mlig455_021851

Neo: -

Age: -

Region-enriched R2: 5.153/0.00077

 MAP3K19 2.428 - 0.735 - 0.709 0.984 - Mlig455_021851 {REF} {Length: 7454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=226.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=217.3]; Ankyrin repeats (3 copies) [PF12796.9, score=113.8]; Ankyrin repeats (many copies) [PF13637.8, score=82.7]; Ankyrin repeats (many copies) [PF13857.8, score=77.3]; F5/8 type C domain [PF00754.27, score=56.3]; Ankyrin repeat [PF00023.32, score=55.9]; Ankyrin repeat [PF13606.8, score=49.9]; ABC1 atypical kinase-like domain [PF03109.18, score=28.7]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=164, Expect=3e-42]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=146, Expect=1e-35]} {Celegans: WBGene00001526, gck-1, Germinal center kinase 1, [Score=139, Expect=2e-33]} {Smed: dd_Smed_v6_10339_0_1, dd_Smed_v6_10339_0_1, [Score=153, Expect=2e-37]} {RNA1509_46581} {RNA1310_9191} {RNA815_12161}
80. MligTC455_40340 201 4.19 Mlig455_021026, Mlig455_021062

Neo: -

Age: -

 2.41 - 0.716 - 0.719 0.975 -

Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069}

Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069}
81. MligTC455_16143 44 0.92 Mlig455_066144

Neo: -

Age: -

 1.911 - 0.956 0.955 - - - Mlig455_066144 {REF} {Length: 1180} {NoTransDecoderORF} {RNA1310_45498} {RNA815_15412}
82. MligTC455_15884 26 0.54 Mlig455_066451

Neo: -

Age: -

Region-enriched R2: 9.632/0.00394

 1.901 - 0.973 - - 0.928 - Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376}
83. MligTC455_54304 298 6.21 Mlig455_027502

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.390

 P4HA2 1.897 - 0.933 - - 0.964 - Mlig455_027502 {REF} {Length: 2991} {Pfam: Prolyl 4-Hydroxylase alpha-subunit, N-terminal region [PF08336.13, score=71.5]; 2OG-Fe(II) oxygenase superfamily [PF13640.8, score=51.0]; Integrase core domain [PF00665.28, score=20.9]} {Human: ENSG00000072682, P4HA2, prolyl 4-hydroxylase subunit alpha 2, [Score=236, Expect=3e-69]} {Mouse: ENSMUSG00000018906, P4ha2, procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide, [Score=233, Expect=2e-68]} {Dmel: FBgn0051014, PH4alphaSG1, prolyl-4-hydroxylase-alpha SG1, [Score=217, Expect=2e-62]} {Celegans: WBGene00001077, dpy-18, Prolyl 4-hydroxylase subunit alpha-1, [Score=231, Expect=1e-67]} {Smed: dd_Smed_v6_6625_0_1, dd_Smed_v6_6625_0_1, [Score=223, Expect=2e-65]} {RNA1509_49019} {RNA1310_6392} {RNA815_15278}
84. MligTC455_11957 20 0.41 Mlig455_019238

Neo: -

Age: -

 1.896 - - 0.923 - 0.973 - Mlig455_019238 {REF} {Length: 956} {RNA1509_48973} {RNA1310_39954.1} {RNA815_19596}
85. MligTC455_14062 16 0.33 Mlig455_041575

Neo: -

Age: -

 1.894 - - 0.959 - 0.935 - Mlig455_041575 {REF} {Length: 1191} {RNA1509_48973} {RNA1310_67118.2} {RNA815_36286}
86. MligTC455_32612 55 1.15 Mlig455_015630

Neo: -

Age: -

Region-enriched R2: 5.626/0.02523

 ARX 1.894 - 0.957 - - 0.937 - Mlig455_015630 {REF} {Length: 2012} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=133, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=118, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=119, Expect=3e-33]} {RNA1310_42333.1} {RNA815_48205}
87. MligTC455_37412 95 1.98 Mlig455_036605, Mlig455_036645

Neo: -

Age: -

 ADRA2A 1.892 - 0.982 - - 0.910 -

Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300}

Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300}
88. MligTC455_23833 17 0.36 Mlig455_016419

Neo: -

Age: -

 MYT1 1.89 - 0.974 - - 0.916 - Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021}
89. MligTC455_21858 21 0.44 Mlig455_045916

Neo: -

Age: -

 SSTR4 1.883 - 0.921 - - 0.962 - Mlig455_045916 {REF} {Length: 1682} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=75.9]} {Human: ENSG00000132671, SSTR4, somatostatin receptor 4, [Score=73.2, Expect=1e-13]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=82.0, Expect=1e-16]} {Dmel: FBgn0250910, Octbeta3R, Octopamine beta3 receptor, [Score=52.0, Expect=6e-07]} {Celegans: WBGene00020712, ckr-1, CholecystoKinin Receptor homolog, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [RH, Score=134, Expect=5e-36]} {RNA1310_148409}
90. MligTC455_24792 19 0.39 Mlig455_045928

Neo: -

Age: -

 CNGB1 1.883 - - 0.906 - 0.977 - Mlig455_045928 {REF} {Length: 3016} {Pfam: Ion transport protein [PF00520.33, score=68.4]; Cyclic nucleotide-binding domain [PF00027.31, score=62.0]} {Human: ENSG00000070729, CNGB1, cyclic nucleotide gated channel beta 1, [Score=420, Expect=5e-130]} {Mouse: ENSMUSG00000031789, Cngb1, cyclic nucleotide gated channel beta 1, [Score=420, Expect=2e-129]} {Dmel: FBgn0266346, CngB, Cyclic nucleotide-gated ion channel subunit B, [Score=468, Expect=1e-150]} {Celegans: WBGene00006525, tax-2, TAX2, [Score=477, Expect=2e-156]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=316, Expect=4e-97]} {RNA1310_34199} {RNA815_36084}
91. MligTC455_35813 35 0.73 Mlig455_013562, Mlig455_013615

Neo: -

Age: -

Region-enriched R2: 7.733/0.00085

 NPR2 1.881 - - - 0.918 0.963 -

Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869}

Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407}
92. MligTC455_34987 27 0.56 Mlig455_031823, Mlig455_047624, Mlig455_047675

Neo: -

Age: -

 KREMEN2 1.878 - 0.897 - - 0.981 -

Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434}

Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434}

Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434}
93. MligTC455_11559 259 5.4 Mlig455_058274, Mlig455_070792

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=0.973

Region-enriched R2: 6.488/0.00000

 1.87 - 0.917 - - 0.953 -

Mlig455_058274 {REF} {Length: 786} {RNA1509_58923} {RNA1310_41706} {RNA815_20876}

Mlig455_070792 {REF} {Length: 891} {RNA1509_58923} {RNA1310_41706} {RNA815_20876}
94. MligTC455_44159 80 1.67 Mlig455_019040, Mlig455_055663

Neo: -

Age: Down-Up-Up

 ADRB1, GALR3 1.869 - - 0.888 - 0.981 -

Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615}

Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615}
95. MligTC455_51198 15 0.3 Mlig455_043152

Neo: -

Age: -

 1.866 - 0.911 - - 0.955 - Mlig455_043152 {REF} {Length: 2583} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.9]} {RNA1310_7738.1} {RNA815_28239}
96. MligTC455_46566 167 3.47 Mlig455_030556

Neo: -

Age: -

Region-enriched R2: 2.352/0.01128

 1.849 - - - 0.880 0.969 - Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594}
97. MligTC455_27785 115 2.39 Mlig455_001141

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-1.796

 HMCN2 1.834 - - 0.881 - 0.953 - Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693}
98. MligTC455_11746 10 0.21 Mlig455_050886

Neo: -

Age: -

 1.829 - - 0.854 - 0.975 - Mlig455_050886 {REF} {Length: 2262} {Pfam: Cryptococcal mannosyltransferase 1 [PF11735.10, score=23.8]} {RNA1509_16212} {RNA1310_23116} {RNA815_8985.1}
99. MligTC455_50410 31 0.64 Mlig455_020239

Neo: -

Age: -

 GRIA2 1.828 - - 0.862 - 0.966 - Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684}
100. MligTC455_08763 20 0.41 Mlig455_061186

Neo: -

Age: -

 1.827 - 0.982 - 0.845 - - Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132}

There are 574 more genes with r >= 0.95  Show all


Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA